Why Hims won't prescribe GLP-1s for weight loss right now

日本 ニュース ニュース

Why Hims won't prescribe GLP-1s for weight loss right now
日本 最新ニュース,日本 見出し
  • 📰 BusinessInsider
  • ⏱ Reading Time:
  • 40 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 19%
  • Publisher: 51%

3 reasons digital-healthcare pioneer Hims is staying out of the latest weight-loss craze for now

two obesity-medicine specialists to its medical-advisory board to help evaluate the market. But Dudum said he thinks it's too early to jump into the ring.

"I don't believe it's in our company's interest to ever be the first mover when it comes to expanding into new categories," Dudum said. Dudum named three major factors about the current state of GLP-1 prescriptions that have given him pause about rolling out a weight-management program at Hims right now — from a lack of evidence of how GLP-1s can affect patients long term, to disruptions in access to the drugs with drug shortages, and unreliable insurance coverage.Dudum expressed concerns about the lack of data on long-term GLP-1 usage for weight loss.

"We're still in the very early innings with regard to what it means long-term, frankly because there have been no patients that have taken this drug long term for obesity," he said.

このニュースをすぐに読めるように要約しました。ニュースに興味がある場合は、ここで全文を読むことができます。 続きを読む:

BusinessInsider /  🏆 729. in US

日本 最新ニュース, 日本 見出し

Similar News:他のニュース ソースから収集した、これに似たニュース記事を読むこともできます。

Why Stephen King Doesn't Write Sequels (& Why He Still Has)Why Stephen King Doesn't Write Sequels (& Why He Still Has)Stephen King has avoided writing sequels to most of his works, and he has a good reason for that, though he has still written a couple of follow-ups.
続きを読む »

Stock trader who returned 2,700% shares top 3 indicators he usesA stock trader who's returned 2,700% in the last 3 years shares the 3 indicators he uses as his guides to buy and sell
続きを読む »

Stock Market Crash: 45% Downside Ahead For S&P 500, Expert WarnsA 31-year market vet who called the current bear market says the S&P 500 has another 45% downside as investors remain blind to signs that a recession is hurtling toward the US economy
続きを読む »

Tesla's cut prices in the US yet again, this time by as much as $5,000Insider tells the global tech, finance, markets, media, healthcare, and strategy stories you want to know.
続きを読む »

29 stocks to buy with underrated earnings: Goldman SachsInsider tells the global tech, finance, markets, media, healthcare, and strategy stories you want to know.
続きを読む »

Coolest cars at the 2023 New York auto show: Lamborghini, Hyundai, ToyotaThe coolest cars we saw at the New York auto show, from a sleek electric Hyundai to an all-terrain Lamborghini
続きを読む »



Render Time: 2025-02-28 20:25:35